A/Prof Paul Griffin
Infectious Diseases Physician and Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland; Principal Investigator and Medical Director at Nucleus Network
What is COVAX-19, the most advanced of Australia’s remaining local COVID vaccine candidates?
A/Prof Paul Griffin | Created on 23 June 2021
To save resource for later, login or sign up as a Healthed member